Evidence map›Paper›PMID 37968386›Full record

ArticleCurrent microbiology2023

First Insight into Drug Resistance Genetic Markers, Glucose-6-Phosphate Dehydrogenase and Phylogenetic Patterns of Misdiagnosed Plasmodium vivax Malaria in Far North Region, Cameroon.

Loick Pradel Kojom Foko, Jahnvi Jakhan, Suman Tamang, Joseph Hawadak, Francine Dorgelesse Kouemo Motse, Vineeta Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Loick Pradel Kojom FokoICMR-National Institute of Malaria Research, Dwarka, Sector 8, New-Delhi, 110077, India.ORCID http://orcid.org/0000-0002-4286-147X
Jahnvi Jakhan *ICMR-National Institute of Malaria Research, Dwarka, Sector 8, New-Delhi, 110077, India.ORCID http://orcid.org/0000-0001-9443-558X
Suman Tamang *ICMR-National Institute of Malaria Research, Dwarka, Sector 8, New-Delhi, 110077, India.ORCID http://orcid.org/0000-0002-2892-2862
Joseph HawadakICMR-National Institute of Malaria Research, Dwarka, Sector 8, New-Delhi, 110077, India.ORCID http://orcid.org/0000-0003-4145-9953
Francine Dorgelesse Kouemo MotseDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, 63, Buea, Cameroon.ORCID http://orcid.org/0000-0002-8676-8576
Vineeta SinghICMR-National Institute of Malaria Research, Dwarka, Sector 8, New-Delhi, 110077, India. vineetas_2000@yahoo.com.ORCID http://orcid.org/0000-0003-0113-7394

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmodium falciparum (Pf) is the predominant malaria species in Africa, but growing rates of non-falciparum species such as P. vivax (Pv) have been reported recently. This study aimed at characterizing drug resistance genes, glucose-6-phosphate dehydrogenase gene (G6PD), and phylogenetic patterns of a Pv + Pf co-infection misdiagnosed as a Pf mono-infection in the Far North region of Cameroon. Only one non-synonymous mutation in the pvdhps gene A383G was found. Pv drug resistance gene sequences were phylogenetically closer to the reference SAL-I strain and isolates from Southeast Asia and Western Pacific countries. Analyzing co-infecting Pf revealed no resistance mutations in Pfmdr1 and Pfk13 genes, but mutations in Pfcrt (C

Indexed as

AntimalarialsMalaria, FalciparumMalaria, VivaxCameroonDiagnostic ErrorsDrug ResistanceGenetic MarkersGlucosephosphate DehydrogenaseHumansPhylogenyPlasmodium falciparumProtozoan ProteinsAntimalarialsG6PD protein, humanGenetic MarkersGlucosephosphate DehydrogenaseProtozoan Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.